← Back to Search

Other

zinc-green tea extract-ascorbic acid for Viral Respiratory Infection

Phase 2
Waitlist Available
Research Sponsored by University of Missouri-Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days of follow-up
Awards & highlights

Study Summary

This trial will assess the effects of zinc and green tea supplementation on symptom duration and severity of colds and flu-like illness, including COVID-19.

Eligible Conditions
  • Viral Respiratory Infection

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days of follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days of follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of recovery from cold and flu-like symptoms
Secondary outcome measures
Rates of patient-reported adverse events
Rates of patient-reported days of absence and/or healthcare visits

Side effects data

From 2016 Phase 1 & 2 trial • 5 Patients • NCT01754987
40%
Elevated Creatinine
40%
Low Platelet count
20%
Dehydration
20%
Thrush
20%
Nosebleed
100%
80%
60%
40%
20%
0%
Study treatment Arm
Ascorbic Acid + Sorafenib
Sorafenib Alone

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: zinc-green tea extract-ascorbic acidExperimental Treatment1 Intervention
Randomized patients will take three (3) capsules taken orally two (2) hours following a meal twice daily x5 days and be blinded to study assignment.
Group II: PlaceboPlacebo Group2 Interventions
Randomized patients will take three (3) capsules taken orally two (2) hours following a meal twice daily x5 days and be blinded to study assignment.

Find a Location

Who is running the clinical trial?

University of Missouri-ColumbiaLead Sponsor
367 Previous Clinical Trials
628,400 Total Patients Enrolled

Media Library

Zinc and Green Tea Extract (Other) Clinical Trial Eligibility Overview. Trial Name: NCT04898023 — Phase 2
Viral Respiratory Infection Research Study Groups: zinc-green tea extract-ascorbic acid, Placebo
Viral Respiratory Infection Clinical Trial 2023: Zinc and Green Tea Extract Highlights & Side Effects. Trial Name: NCT04898023 — Phase 2
Zinc and Green Tea Extract (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04898023 — Phase 2
~6 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top